Nuwellis Unveils New 24-Hour Aquadex Circuit for Outpatient and Short-Term Fluid Management
ByAinvest
Thursday, Sep 4, 2025 8:16 am ET1min read
SSKN--
The E360 program has driven a 7% average annual growth (YoY) for participating clinics and has facilitated new clinic partnership agreements with STRATA. Dr. Dolev Rafaeli, the company's President and CEO, commented, "The Elevate 360 program helps clinics not only maintain optimal care for their patients but also optimize their business operations. We provide turn-key marketing solutions, optimize business systems, and ensure clinics are able to attract and retain patients effectively."
The program assists clinics in completing the end-to-end process of providing treatment, including identifying new patient referrals, securing reimbursement, and scheduling follow-up visits. This comprehensive approach has shown significant improvement in partner clinic top and bottom lines.
STRATA's success with the E360 program underscores the company's commitment to driving growth for its partner clinics while expanding its own market reach. As clinics continue to adopt the E360 platform, STRATA is poised to benefit from increased revenue streams and a larger network of partner clinics.
[1] https://www.globenewswire.com/news-release/2025/09/04/3144490/23161/en/STRATA-Skin-Sciences-Elevate-360-Consulting-Offering-Drives-Growth-in-Partner-Clinic-Operations-and-Fuels-New-Partnership-Agreements.html
STRATA Skin Sciences reports growth in partner clinics adopting its Elevate 360 consulting services platform, which helps clinics maximize revenue potential through marketing, reimbursement, and patient retention tactics. The program has driven a 7% average growth YoY for participating clinics and has fueled new clinic partnership agreements with STRATA.
STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company specializing in dermatology treatments, has reported significant growth in its partner clinics adopting the Elevate 360 (E360) consulting services platform. This platform aims to help clinics maximize their revenue potential through best practices in marketing, reimbursement, and patient retention.The E360 program has driven a 7% average annual growth (YoY) for participating clinics and has facilitated new clinic partnership agreements with STRATA. Dr. Dolev Rafaeli, the company's President and CEO, commented, "The Elevate 360 program helps clinics not only maintain optimal care for their patients but also optimize their business operations. We provide turn-key marketing solutions, optimize business systems, and ensure clinics are able to attract and retain patients effectively."
The program assists clinics in completing the end-to-end process of providing treatment, including identifying new patient referrals, securing reimbursement, and scheduling follow-up visits. This comprehensive approach has shown significant improvement in partner clinic top and bottom lines.
STRATA's success with the E360 program underscores the company's commitment to driving growth for its partner clinics while expanding its own market reach. As clinics continue to adopt the E360 platform, STRATA is poised to benefit from increased revenue streams and a larger network of partner clinics.
[1] https://www.globenewswire.com/news-release/2025/09/04/3144490/23161/en/STRATA-Skin-Sciences-Elevate-360-Consulting-Offering-Drives-Growth-in-Partner-Clinic-Operations-and-Fuels-New-Partnership-Agreements.html

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet